Skip to main content

EU Court Asks EFSA To Reveal Glyphosate Cancer Studies

EU Court Asks EFSA To Reveal Glyphosate Cancer Studies

EU Court Asks EFSA To Reveal Glyphosate Cancer Studies

Introduction

On Thursday, EU court ruled that the European Food Safety Agency (EFSA) must disclose to European lawmakers the details of studies about the dangers and carcinogenic nature of glyphosate in support of the campaigners who want Roundup weedkiller banned.

In the statement released, the European Court of Justice’s General Court told that the intent was to give the general public access to the research information, along with the knowledge of what is or could be released into the environment and understand the severity of that release. Judges recalled two decisions by EFSA that denied access to the research details. Green members of the European Parliament brought the two cases. The agency's spokesperson told, "EFSA welcomes the decision. This case, and the Court’s ruling is important because it provides orientation for EFSA and others charged with interpreting EU legislation on public access to documents." Monsanto sold glyphosate-containing herbicide under the brand name Roundup. Presently, it is off-patent and marketed by dozens of other distributors including Dow AgroSciences and Germany’s BASF. In 2015, a World Health Organization agency raised concerns about glyphosate's safety and effectiveness while concluding that it was a probable reason for cancer in humans.

Roundup bellwether trials are currently underway in the Northern District of California, where  Judge Vince Chhabria overlooks the multidistrict litigation (MDL No. 2741; In re: Roundup Products Liability Litigation).

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!